The vulnerable carotid artery plaque: Current imaging methods and new perspectives

Stroke

Volumn 36, Issue 12, 2005, Pages 2764-2772

  Nighoghossian, Norbert ^a,b,c   Derex, Laurent ^a,b   Douek, Philippe ^b  

^a Cerebrovascular Unit   (France)

^b LOUIS PRADEL HOSPITAL   (France)

^c HÔPITAL NEUROLOGIQUE   (France)

Author keywords

Carotid plaque vulnerability; Imaging; Therapy

Indexed keywords

ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; B SCAN; CAROTID ARTERY; CLINICAL PRACTICE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; HUMAN; INFLAMMATORY DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; CAROTID ARTERY OBSTRUCTION; CAROTID ENDARTERECTOMY; DIAGNOSTIC IMAGING; DRUG ANTAGONISM; DRUG POTENTIATION; ECHOGRAPHY; METHODOLOGY; PATHOLOGY;

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CHONDROCYTE GROWTH FACTORS; CILOSTAZOL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERCELLULAR ADHESION MOLECULE 1; MATRIX METALLOPROTEINASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PROTEIN; TETRAZOLE DERIVATIVE;

ANTICOAGULANTS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CAROTID ARTERIES; CAROTID STENOSIS; DIAGNOSTIC IMAGING; ENDARTERECTOMY, CAROTID; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INTERCELLULAR ADHESION MOLECULE-1; MATRIX METALLOPROTEINASES; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; PLATELET AGGREGATION INHIBITORS; PROTEINS; TETRAZOLES;

EID: 33644680768     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.0000190895.51934.43     Document Type: Review

References (77)

1. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C. Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet. 1991;337:1521-1526.
2. Barnett HJ, Taylor DW, Eliasziw M, Fox AJ, Ferguson GG, Haynes RB, Rankin RN, Clagett GP, Hachinski VC, Sackett DL, Thorpe KE, Meldrum HE, Spence JD. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med. 1998;12;339:1415-1425.
3. European Carotid Surgery Trialists Collaborative Group. Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet. 1998;351:1379-1387.
4. Executive Committee for the Asymptomatic Carotid Atherosclerosis Study. Endarterectomy for asymptomatic carotid artery stenosis. JAMA. 1995;273:1421-1428.
5. MRC Asymptomatic Carotid Surgery Trial (ACST) Collaborative Group. Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial. Lancet. 2004;363:1491-1502.
6. Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J, Badimon JJ, Stefanadis C, Moreno P, Pasterkamp G, Fayad Z, Stone PH, Waxman S, Raggi P, Madjid M, Zarrabi A, Burke A, Yuan C, Fitzgerald PJ, Siscovick DS, de Korte CL, Aikawa M, Airaksinen KE, Assmann G, Becker CR, Chesebro JH, Farb A, Galis ZS, Jackson C, Jang IK, Koenig W, Lodder RA, March K, Demirovic J, Navab M, Priori SG, Rekhter MD, Bahr R, Grundy SM, Mehran R, Colombo A, Boerwinkle E, Ballantyne C, Insull W Jr, Schwartz RS, Vogel R, Serruys PW, Hansson GK, Faxon DP, Kaul S, Drexler H, Greenland P, Muller JE, Virmani R, Ridker PM, Zipes DP, Shah PK, Willerson JT. From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation. 2003;108:1664-1672.
7. Faxon DP, Fuster V, Libby P, Beckman JA, Hiatt WR, Thompson RW, Topper JN, Annex BH, Rundback JH, Fabunmi RP, Robertson RM, Loscalzo J; for the American Heart Association. Atherosclerotic Vascular Disease Conference: Writing Group III: pathophysiology. Circulation. 2004 1;109:2617-2625.
8. Hollander M, Hak AE, Koudstaal PJ, Bots ML, Grobbee DE, Hofman A, Witteman JCM, Breteler MMB. Comparison between measures of atherosclerosis and risk of stroke, The Rotterdam Study. Stroke. 2003;34:2367-2373.
9. Farb A, Burke AP, Tang AL, Liang TY, Mannan P, Smialek J, Virmani R. Coronary plaque erosion without rupture into a lipid core. A frequent cause of coronary thrombosis in sudden coronary death. Circulation. 1996;1;93:1354-1363.
10. Meairs S, Timpe L, Beyer J, Hennerici M. Acute aphasia and hemiplegia during karate training. Lancet. 2000;356:40.
11. Rothwell PM, Villagra R, Gibson R, Donders RC, Warlow CP. Evidence of a chronic systemic cause of instability of atherosclerotic plaques. Lancet. 2000;1:355:19-24.
12. Fisher M, Paganini-Hill, Martin A, Cosgrove M, Toole JF, Barnett JM, Norris J. Carotid plaque pathology thrombosis, ulceration, and stroke pathogenesis. Stroke. 2005;36:253-257.
13. Sitzer M, Muller W, Siebler M, Hort W, Kniemeyer H-W, Jancke L, Steinmetz H. Plaque ulceration and lumen thrombus are the main sources of cerebral microemboli in high-grade internal carotid artery stenosis. Stroke. 1995;26:1231-1233.
14. Rothwell PM, Gutnikov SA, Warlow CP. European Carotid Surgery Trialist's collaboration. Reanalysis of the final results of the European Carotid Surgery Trialist's Collaboration. Stroke. 2003;34:514-523.
15. Nandalur KR, Baskurt E, Hagspiel KD, Phillips CD, Kramer CM. Calcified carotid atherosclerotic plaque is associated less with ischemic symptoms than is noncalcified plaque on MDCT. AJR Am J Roentgenol. 2005;184:295-298.
16. Shaalan WE, Cheng H, Gewertz B, McKinsey JF, Schwartz LB, Katz D, Cao D, Desai T, Glagov S, Bassiouny HS. Degree of carotid plaque calcification in relation to symptomatic outcome and plaque inflammation. J Vasc Surg. 2004;40:262-269.
17. Kolodgie FD, Gold HK, Burke AP, Fowler DR, Knuth HS, Weber DK, Farb A, Guerrero LJ, Hayase M, Kutys R, Narula J, Finn AV, Virmani R. Intraplaque hemorrhage and progression of coronary atheroma. N Engl J Med. 2003;349:2316-2325.
18. Imparato AM, Riles TS, Mintzer R, Baumann FG. The importance of hemorrhage in the relationship between gross morphologic characteristics and cerebral symptoms in 376 carotid artery plaques. Ann Surg. 1983;197:195-203.
19. Montauban van Swijndregt AD, Elbers HR, Moll FL, de Letter J, Ackerstaff RG. Cerebral ischemic disease and morphometric analyses of carotid plaques. Ann Vasc Surg. 1999;13:468-474.
20. Spagnoli LG, Mauriello A, Sangiorgi G, Fratoni S, Bonanno E, Schwartz RS, Piepgras DG, Pistolese R, Ippoliti A, Holmes DR Jr. Extracranial thrombotically active carotid plaque as a risk factor for ischemic stroke. JAMA. 2004;20:292:1845-1852.
21. De Graba TJ, Siren AL, Penix L, McCarron RM, Hargraves R, Sood S, Pettigrew KD, Hallenbeck JM. Increased endothelial expression of intercellular adhesion molecule-1 in symptomatic versus asymptomatic human carotid atherosclerotic plaque. Stroke. 1998;29:1405-1410.
22. Nuotio K, Lindsberg PJ, Carpen O, Soinne L, Lehtonen-Smeds EM, Saimanen E, Lassila R, Sairanen T, Sarna S, Salonen O, Kovanen PT, Kaste M. Adhesion molecule expression in symptomatic and asymptomatic carotid artery stenosis. Neurology. 2003;24:60:1890-1899.
23. Johnson JL, Jackson CL, Angelini GD, George SJ. Activation of matrix-degrading metalloproteinases by mast cells in atherosclerotic plaques. Arterioscler Thromb Vasc Biol. 1998;18:1707-1715.
24. Morgan A, Rerkasem K, Gallagher P, Zhang B, Morris G, Calder P, Grimble R, Eriksson P, McPheat W, Shearman C, Ye S. Differences in matrix metalloproteinase-1 and matrix metalloproteinase-12 transcript levels among carotid atherosclerotic plaques with different histopathological characteristics. Stroke. 2004;35:1310-1315.
25. Johnson JL, George S, Newby A, Jackson CP. Matrix metalloproteinases-9 and -12 have opposite effects on atherosclerotic plaque stability. Atherosclerosis. 2003;169:199.
26. Cipollone F, Fazia M, Mincione G, Iezzi A, Pini B, Cuccurullo C, Ucchino S, Spigonardo F, Di Nisio M, Cuccurullo F, Mezzetti A, Porreca E. Increased expression of transforming growth factor-β1 as a stabilizing factor in human atherosclerotic plaques. Stroke. 2004;35:2253-2257.
27. Jander S, Sitzer M, Wendt A, Schroeter M, Buchkremer M, Siebler M, Muller W, Sandmann W, Stoll G. Expression of tissue factor in high-grade carotid artery stenosis: association with plaque destabilization. Stroke. 2001;32:850-854.
28. Grau AJ, Boddy AW, Dukovic DA, Buggle F, Lichy C, Brandt T, Hacke W; for the CAPRIE investigators. Leukocyte count as an independent predictor of recurrent ischemic events. Stroke. 2004;35:1147-1152.
29. Johnsen SH, Fosse E, Joakimsen O, Mathiesen EB, Stensland-Bugge E, NjØlstad, Amesen E. Monocyte count is a predictor of novel plaque formation. A 7-year follow-up study of 2610 persons without carotid plaque at baseline. The TromsØ Study. Stroke. 2005;36:715-719.
30. Rothwell PM, Howard SC, Power DA, Gutnikov SA, Algra A, van Gijn J, Clark TG, Murphy MF, Warlow CP. Fibrinogen concentration and risk of ischemic stroke and acute coronary events in 5513 patients with transient ischemic attack and minor ischemic stroke. Stroke. 2004;35:2300-2305.
31. Mauriello A, Sangiorgi G, Palmieri G, Virmani R, Holmes DR Jr, Schwartz RS, Pistolese R, Ippoliti A, Spagnoli LG. Hyperfibrinogenemia is associated with specific histological composition and complications of atherosclerotic carotid plaques in patients affected by transient ischemic attacks. Circulation. 2000;22;101:744-750.
32. Choi H, Cho DH, Shin HH, Park JB. Association of high sensitivity C-reactive protein with coronary heart disease prediction, but not with carotid atherosclerosis, in patients with hypertension. Circ J. 2004;68:297-303.
33. Dosa E, Rugonfalvi-Kiss S, Prohaszka Z, Szabo A, Karadi I, Selmeci L, Romics L, Fust G, Acsady G, Entz L. Marked decrease in the levels of two inflammatory markers, hs-C-reactive protein and fibrinogen in patients with severe carotid atherosclerosis after eversion carotid endarterectomy. Inflamm Res. 2004;53:631-635.
34. Flex A, Gaetani E, Papaleo P, Straface G, Proia AS, Pecorini G, Tondi P, Pola P, Pola R. Proinflammatory genetic profiles in subjects with history of ischemic stroke. Stroke. 2004;35:2270-2275.
35. Jerrard-Dunne P, Sitzer M, Risley P, Buehler A, von Kegler S, Markus HS. Inflammatory gene load is associated with enhanced inflammation and early carotid atherosclerosis in smokers. Stroke. 2004;35:2438-2443.
36. Fleiner M, Kummer M, Mirlacher M, Sauter G, Cathomas G, Krapf R, Biedermann BC. Arterial neovascularization and inflammation in vulnerable patients: early and late signs of symptomatic atherosclerosis. Circulation. 2004;2;110: 2843-2850.
37. Traub O, Berk BC. Laminar shear stress: mechanisms by which endothelial cells transducer an atheroprotective force. Arterioscler Thromb Vasc Biol. 1998;18:677-685.
38. Resnick N, Collins T, Atkinson W, Bonthron DT, Dewey CF Jr, Gimbrone MA Jr. Platelet-derived growth factor B chain promoter contains a cis-acting fluid shear stress responsive element. Proc Natl Acad Sci U S A. 1993;90:7908.
39. Lovett JK, Redgrave JNE, Rothwell PM. A critical appraisal of the performance, reporting, and interpretation of studies comparing carotid plaque imaging with histology. Stroke. 2005;36.5;1091-1097.
40. Toussaint JF, Glenn M. Muraglia L, Southern JF, Fuster V, Kantor HL. Magnetic resonance images lipid, fibrous, calcified, hemorrhagic, and thrombotic components of human atherosclerosis in vivo. Circulation. 1996;94:932-938.
41. Yuan C, Zhang SX, Polissar NL, Echelard D, Ortiz G, Davis JW, Ellington E, Ferguson MS, Hatsukami TS. Identification of fibrous cap rupture with magnetic resonance imaging is highly associated with recent transient ischemic attack or stroke. Circulation. 2002;15;105:181-185.
42. Cai JM, Hatsukami TS, Ferguson MS, Small R, Polissar NL, Yuan C. Classification of human carotid atherosclerotic lesions with in vivo multicontrast magnetic resonance imaging. Circulation. 2002;10;106:1368-1373.
43. Saam T, Ferguson MS, V.L. Yarnykh, N. Takaya, D. Xu, N.L. Polissar NL, Hatsukami TS, Yuan C. Quantitative evaluation of carotid plaque composition by in vivo MRI. Arterioscler Thromb Vasc Biol. 2005;25:234-239.
44. Bruce A. Wasserman WI, Trout HH, Cannon RO, Balaban RS, Arai AE. Carotid artery atherosclerosis; in vivo morphologic characterization with Gadolinium-enhanced double-oblique MR imaging - initial results. Radiology. 2002;223:566-573.
45. Kerwin W, Hooker A, Spilker M, Vicini P, Ferguson M, Hatsukami TS, Yuan C. Quantitative magnetic resonance imaging analysis neovasculature volume in carotid atherosclerotic plaque. Circulation. 2003;107:851-856.
46. Corti R, Osende JI, Fayad ZA, Fallon JT, Fuster V, Mizsei G, Dickstein E, Drayer B, Badimon JJ. In vivo noninvasive detection and age definition of arterial thrombus by MRI. J Am Coll Cardiol. 2002;17;39: 1366-1373.
47. Viereck J, Ruberg FL, Qiao Y, Perez AS, Detwiller K, Johnstone M, Hamilton JA. MRI of atherothrombosis associated with plaque rupture, Arterioscler Thromb Vasc Biol. 2005;25:240-245.
48. Moody AR, Murphy RE, Morgan PS, Martel AL, Delay GS, Allder S, MacSweeney ST, Tennant WG, Gladman J, Lowe J, Hunt BJ. Characterization of complicated carotid plaque with magnetic resonance direct thrombus imaging in patients with cerebral ischemia. Circulation. 2003;107:3047-3052.
49. Murphy RE, Moody AR, Morgan PS, Martel AL, Delay GS, Allder S, MacSweeney ST, Tennant WG, Gladman J, Lowe J, Hunt BJ. Prevalence of complicated carotid atheroma as detected by magnetic resonance direct thrombus imaging in patients with suspected carotid artery stenosis and previous acute cerebral ischemia. Circulation. 2003;107:3053-3058.
50. Takaya N, Yuan C, Chu B, Saam T, Polissar NL, Jarvik GP, Isaac C, McDonough J, Natiello C, Small R, Ferguson MS, Hatsukami TS. Presence of intraplaque hemorrhage stimulates progression of carotid atherosclerotic plaques. A high-resolution magnetic resonance imaging study. Circulation. 2005;111:2768-2775.
51. Kampschulte A, Ferguson MS, Kerwin WS, Nayak L. Polissar, Chu B, Saam T, Hatsukami TS, Yuan C. Differentiation of intraplaque versus juxtaluminal hemorrhage/thrombus in advanced human carotid atherosclerotic lesions by in vivo magnetic resonance imaging. Circulation. 2004;110:3239-3244.
52. Nissen SE, Yock P. Intravascular ultrasound: novel pathophysiological insights and current clinical applications. Circulation. 2001;103:604-616.
53. Pignoli P, Tremoli E, Poli A, Oreste P, Pacletti R. Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation. 1986;74:1399-1406.
54. Clark DJ, Lessio S, O'Donoghue M, Schainfeld R, Rosenfield K. Safety and utility of intravascular ultrasound-guided carotid artery stenting. Catheter Cardiovasc Interv. 2004;63:355-362.
55. Choudhury RP, Fuster V, Fayad ZA. Molecular, cellular and functional imaging of atherothrombosis. Nat Rev Drug Disc. 2004;3:913-925.
56. Weissleder R, Mahmood U. Molecular imaging. Radiology. 2001;40:219-316.
57. Jaffer FA, Weissleder R. Molecular imaging in the clinical arena. JAMA. 2005;16;293:855-862.
58. Kooi ME, Cappendijk VC, Cleutjens KB, Kessels AG, Kitslaar PJ, Borgers M, Frederik PM, Daemen MJ, van Engelshoven JM. Accumulation of ultrasmall superparamagnetic particles of iron oxyde in human atherosclerotic plaques can be detected by in vivo magnetic resonance imaging. Circulation. 2003;107:2453-2458.
59. Trivedi RA, U-King-Im JM, Graves MJ, Cross JJ, Horsley J, Goddard MJ, Skepper JN, Quartey G, Warburton E, Joubert I, Wang L, Kirkpatrick PJ, Brown J, Gillard JH. In vivo detection of macrophages in human carotid atheroma; temporal dependence of ultrasmall superparamagnetic particles of iron oxide-enhanced MRI. Stroke. 2004;35:1631-1635.
60. Jaffer FA, Weissleder R. Seeing within: molecular imaging of the cardiovascular system. Circ Res. 2004;94:433-445.
61. Winter PM, Caruthers SD, Yu X, Song SK, Chen J, Miller B, Bulte JW, Robertson JD, Gaffney PJ, Wickline SA, Lanza GM. Improved molecular imaging contrast agent for detection of human thrombus. Magn Reson Med. 2003;50:411-416.
62. Winter PM, Morawski AM, Caruthers SD, Fuhrhop RW, Zhang H, Williams TA, Allen JS, Lacy EK, Robertson JD, Lanza GM, Wickline SA. Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha (v) beta3-integrin- targeted nanoparticles. Circulation. 2003;4: 108:2270-2274.
63. Lindner JR. Microbubbles in medical imaging: current applications and future directions. Nat Rev Drug Discov. 2004;3:527-532.
64. Chen J, Tung CH, Mahmood U, Ntziachristos V, Gyurko R, Fishman MC, Huang PL, Weissleder R. In vivo imaging of proteolytic activity in atherosclerosis. Circulation. 2002;105:2766-2771.
65. Falati S, Gross P, Merill-Skoloff G, Furie B. Real time in vivo imaging of platelets, tissue factor and fibrin during arterial thrombus formation in the mouse. Nat Med. 2002;8:1175-1181.
66. Kietselaer BL, Reutelingsperger CP, Heindendal GA, Daemen MJ, Mess WH, Hofstra L, Narala J. Noninvasive detection of plaque instability with use of radiolabeled annexin A5 in patients with carotid-artery atherosclerosis. N Engl J Med. 2004;350:1472-1473.
67. Rudd JH, Warburton EA, Fryer TD, Jones HA, Clark JC, Antoun N, Johnstrom P, Davenport AP, Kirkpatrick PJ, Arch BN, Pickard JD, Weissberg PL. Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography. Circulation. 2002;11; 105:2708-2711.
68. Diener HC, Ringleb P. Antithrombotic secondary prevention after stroke. Curr Treat Options Neurol. 2001;3:451-462.
69. Diener HC, Bogousslavsky J, Brass LM, Cimminiello C, Csiba L, Kaste M, Leys D, Matias-Guiu J, Rupprecht HJ, for the MATCH Investigators. Aspirin and clopidogrel compared with clopidogrel alone after ischemic stroke or transient ischemic attack in high risk patients (MATCH): randomised, double-blind- controled trial. Lancet. 2004;24:364:331-337.
70. Markus HS, Droste DW, Kaps M, Larrue V, Lees KR, Siebler M, Ringelstein B. Dual antiplatelet therapy with clopidogrel and aspirin in symptomatic carotid stenosis evaluated using Doppler embolic signal detection. The clopidogrel and aspirin for reduction of emboli in symptomatic carotid stenosis (CARESS) trial. Circulation. 2005;111:2233-2240.
71. Chimowitz MI, Lynn MJ, Smith HH, Stern BJ, Hertzberg VS, Frankel MR, Levine SR, Chatuverdi S, Kasner SE, Benesch CG, Sila CA, Jovin TG, Romano JG, for the Warfarin-Aspirin Symptomatic Intracranial Disease Trial Investigators. Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis. N Engl Med 2005;352:1305-1316.
72. Amarenco P, Labreuche J, Lavallée P, Touboul PJ. Statins in stroke prevention and carotid atherosclerosis. Systematic review and up-to-date meta-analysis. Stroke. 2004;35:2902-2909.
73. Crisby M, Nordin-Fredriksson G, Shah PK, Yano J, Zhu J, Nilsson J. Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization. Circulation. 2001;103:926-933.
74. Coward LJ, Featherstone RL, Brown MM. Safety and Efficacy of endovascular treatment of carotid artery stenosis compared with carotid endarterectomy. A Cochrane Systematic Review of the Randomized evidence. Stroke. 2005;36:905.
75. Kwon SU, Cho YJ, Koo JS, Bae HJ, Lee YS, Hong KS, Lee JH, Kim JS. Cilostazol prevents the progression of the symptomatic intracranial arterial stenosis. The multicenter double-blind placebo-controlled trial of cilostazol in symptomatic intra-cranial stenosis. Stroke. 2005;36:782-786.
76. Tao L, Liu HR, Gao E, Teng ZP, Lopez BL, Christofer TA, Ma XL, Batinic-Haberle I, Willette RN, Ohlstein EH, Yue TL. Antioxydative, antinitrative, and vasculoprotective effects of a peroxisome proliferators-activated receptor-γ agonist in hypercholesterolemia. Circulation. 2003;2:108:2805-2811.
77. Levitt NC, Eskens FA, O'Byrne KJ, Propper DJ, Denis LJ, Owen SJ, Choi L, Foekens JA, Wilner S, Wood JM, Nakajima M, Talbot DC, Steward WP, Harris AL, Verweij J. Phase I and pharmacological study of the oral matrix metalloproteinase inhibitor, MMI270 (CGS27023A), in patients with advanced solid cancer. Clin Cancer Res. 2001;7:1912-1922.